• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore , Aug 14

Strides Arcolab has announced that it has received tentative USFDA approval for one of its ANDA filings for AIDS drugs.

Nevirapine, filed for selling as 200 mg tablets, has received approval for its ANDAs (abbreviated new drug application), the Bangalore-based Strides said in a release.

The application was reviewed under the expedited review provisions of the US President's Emergency Plan for AIDS Relief.

Four more applications are under review for the same programme and four more are to be submitted.

"This approval represents significant opportunity for Strides to commercialise Nevirapine, a key anti-retro viral in the treatment of AIDS," said Mr Arun Kumar, Vice-Chairman and CEO.

.

More Stories on : Regulatory Bodies & Rulings | Health | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Fire at Century's cement plant

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line